Regional Analysis

Global Herpes Simplex Virus Treatment Market: Regional Insights

Based on geography, the global herpes simplex virus treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the rising incidence of herpes simplex virus infections, rising health expenditure, and introduction of safe and effective therapeutics in the region. For instance, genital herpes is the common sexually transmitted disease in the United States. According to the Centers for Disease Control and Prevention (CDC), more than 572,000 new genital herpes infections occur each year in the U.S. Herpes simplex virus type 2 (HSV-2) is mainly sexually transmitted and causes genital herpes. Both oral and genital herpes are mostly asymptomatic or unrecognized.

Europe and Asia Pacific are also expected to witness robust growth in the global herpes simplex virus treatment market owing to the growing prevalence of infections of the herpes simplex virus, increase in research and development activities, and rise in demand for safe/effective therapeutics in these regions. For instance, According to the study entitled ‘Epidemiology of herpes simplex virus type 2 in Europe, published in the Lancet Regional Health-Europe in December 2022, about 10% of the population of Europe is infected with the herpes simplex virus type 2 (HSV-2). The prevalence was more common in women than men.

Figure 1. Global Herpes Simplex Virus Treatment Market Share (%), By Region, 2023